These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Pharmacological and toxicological properties of creatinol O-phosphate. A review. Marzo A; Ghirardi P Arzneimittelforschung; 1979; 29(9a):1449-52. PubMed ID: 395957 [TBL] [Abstract][Full Text] [Related]
6. Protective effect of creatinol O-phosphate (COP) on ventricular fibrillation and death induced by intravenous CaCl2 in mice. Ferrini R; Miragoli G Arzneimittelforschung; 1979; 29(9a):1473-4. PubMed ID: 575496 [TBL] [Abstract][Full Text] [Related]
7. Protective effect of creatinol O-phosphate (COP) on some experimental arrhythmias in vitro and in vivo. Ferrini R; Miragoli G Arzneimittelforschung; 1979; 29(9a):1475-7. PubMed ID: 575497 [TBL] [Abstract][Full Text] [Related]
8. [Electrophysiologic effects of dopamine on the cardiac conduction system (author's transl)]. Bischoff KO; Hager W; Bödeker K Z Kardiol; 1981 Sep; 70(9):643-51. PubMed ID: 7303803 [TBL] [Abstract][Full Text] [Related]
9. Effects of creatinol O-phosphate on serum enzymes in acute myocardial infarction. Knippel M; Bana G; Pusterla GL Arzneimittelforschung; 1979; 29(9a):1480-2. PubMed ID: 575498 [TBL] [Abstract][Full Text] [Related]
10. [Effect of a new anti-arrhythmia preparation ethacizin (a diethylamine analog of ethmozin) on the heart conduction system in different forms of heart rhythm disorder]. Smetnev AS; Shugushev KhKh; Rozenshtraukh LV; Shevchenko NM Ter Arkh; 1983; 55(1):92-5. PubMed ID: 6340241 [No Abstract] [Full Text] [Related]
11. The effect of atropine on cardiac arrhythmias and conduction. Part 1. Schweitzer P; Mark H Am Heart J; 1980 Jul; 100(1):119-27. PubMed ID: 6992549 [No Abstract] [Full Text] [Related]
12. Protective action of creatinol O-phosphate against serum CPK activity enhanced by isoprenaline in the rat. Marzo A; Ghirardi P Arzneimittelforschung; 1979; 29(9a):1471-3. PubMed ID: 575495 [TBL] [Abstract][Full Text] [Related]
13. Creatinol O-phosphate therapy in patients with inadequate coronary circulation. Double-blind clinical trial. Barlattani M; Guglielmi G; Mammarella A Arzneimittelforschung; 1979; 29(9a):1483-5. PubMed ID: 395958 [TBL] [Abstract][Full Text] [Related]
14. The electrophysiology of propranolol in man. Seides SF; Josephson ME; Batsford WP; Weisfogel GM; Lau SH; Damato AN Am Heart J; 1974 Dec; 88(6):733-41. PubMed ID: 4419628 [No Abstract] [Full Text] [Related]
15. Electrophysiology of atropine. Bissett JK; de Soyza ND; Kane JJ; Murphy ML Cardiovasc Res; 1975 Jan; 9(1):73-80. PubMed ID: 804352 [TBL] [Abstract][Full Text] [Related]
16. [Electrophysiologic properties of acebutolol in man]. Touboul P; Huerta F; Porte J; Delahaye JP Therapie; 1975; 30(3):417-27. PubMed ID: 1224363 [No Abstract] [Full Text] [Related]
18. Depressant effect on the retrograde atrioventricular nodal conduction of beta-adrenergic blockade by propranolol in humans. Shenasa M; Lacombe P; Côté MA; Sadr-Ameli MA; Nadeau R Can J Cardiol; 1987 Sep; 3(6):281-7. PubMed ID: 3427528 [TBL] [Abstract][Full Text] [Related]
19. The electrophysiology of Norpace (Part III). Caracta A Angiology; 1975 Jan; 26(1 Pt 2):120-3. PubMed ID: 1115399 [No Abstract] [Full Text] [Related]
20. [Functional longitudinal dissociation of the nodal-His bundle conduction system in the electrophysiological study of a "short PR with narrow QRS"]. Baudouy M; Camous JP; Varenne A; Guarino L; Patouraux G; Guiran JB Arch Mal Coeur Vaiss; 1980 Dec; 73(12):1407-14. PubMed ID: 6779728 [No Abstract] [Full Text] [Related] [Next] [New Search]